Syra Health Corp. Cl A (SYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,688 | 1,946 | 1,858 | 2,007 | 2,253 |
| Cost of Goods | 1,133 | 1,193 | 1,269 | 1,672 | 1,585 |
| Gross Profit | 555 | 753 | 589 | 335 | 668 |
| Operating Expenses | 920 | 1,009 | 1,331 | 1,508 | 1,682 |
| Operating Income | -232 | -63 | -473 | -502 | -429 |
| Interest Expense | 2 | 4 | 3 | 6 | 2 |
| Other Income | 8 | 4 | 4 | 3 | 14 |
| Pre-tax Income | -226 | -64 | -472 | -504 | -418 |
| Net Income Continuous | -226 | -64 | -472 | -504 | -418 |
| Net Income | $-226 | $-64 | $-472 | $-504 | $-418 |
| EPS Basic Total Ops | -0.02 | -0.01 | -0.04 | -0.01 | -0.06 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.04 | -0.01 | -0.06 |
| EPS Diluted Total Ops | -0.02 | -0.01 | -0.04 | -0.01 | -0.06 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.04 | -0.01 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.01 | -0.04 | -0.05 | -0.06 |
| EBITDA(a) | $-227 | $-57 | $-467 | $-494 | $-403 |